Retrospective Analysis of Immune Checkpoint Inhibitors in NSCLC: Immune-Related Adverse Events and Outcomes

被引：0
|
作者：
Lee, A. [1 ]
Luong, M. [2 ]
Ohana, D. [2 ]
Forster, M. [1 ]
Lee, S. M. [1 ]
机构：
[1] UCL, Inst Canc, London, England
[2] Univ Coll Hosp, Canc Div, London, England
来源：
JOURNAL OF THORACIC ONCOLOGY | 2019年 / 14卷 / 10期
关键词：
immuno-oncology; NSCLC; irAE;
D O I：
10.1016/j.jtho.2019.08.1573
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P2.04-68
引用
收藏
页码：S734 / S735
页数：2
相关论文
共 50 条
  • [41] Immune-related adverse events: promising predictors for efficacy of immune checkpoint inhibitors
    Li Zhong
    Qing Wu
    Fuchun Chen
    Junjin Liu
    Xianhe Xie
    [J]. Cancer Immunology, Immunotherapy, 2021, 70 : 2559 - 2576
  • [42] Haematological immune-related adverse events with immune checkpoint inhibitors, how to manage?
    Michot, J. M.
    Lazarovici, J.
    Tieu, A.
    Champiat, S.
    Voisin, A. L.
    Ebbo, M.
    Godeau, B.
    Michel, M.
    Ribrag, V.
    Lambotte, O.
    [J]. EUROPEAN JOURNAL OF CANCER, 2019, 122 : 72 - 90
  • [43] Immune-related adverse events: promising predictors for efficacy of immune checkpoint inhibitors
    Zhong, Li
    Wu, Qing
    Chen, Fuchun
    Liu, Junjin
    Xie, Xianhe
    [J]. CANCER IMMUNOLOGY IMMUNOTHERAPY, 2021, 70 (09) : 2559 - 2576
  • [44] Do immune-related adverse events correlate with response to immune checkpoint inhibitors?
    Saleh, Khalil
    Khalife-Saleh, Nadine
    Kourie, Hampig Raphael
    [J]. IMMUNOTHERAPY, 2019, 11 (04) : 257 - 259
  • [45] Immune-related adverse events associated with immune checkpoint inhibitors in patients with cancer
    Samanci, Nilay Sengul
    Cikman, Duygu Ilke
    Oruc, Kerem
    Bedir, Sahin
    Celik, Emir
    Degerli, Ezgi
    Derin, Sumeyra
    Demirelli, Fuat Hulusi
    oezgueroglu, Mustafa
    [J]. TUMORI JOURNAL, 2021, 107 (04): : 304 - 310
  • [46] Vitamin D, autoimmunity and immune-related adverse events of immune checkpoint inhibitors
    Lillian Sun
    Joshua Arbesman
    Melissa Piliang
    [J]. Archives of Dermatological Research, 2021, 313 : 1 - 10
  • [47] Assessment of hospitalization rates for immune-related adverse events with immune checkpoint inhibitors
    Nice, Laura
    Bycroft, Ryan
    Wu, Xiaoyong
    Rai, Shesh N.
    Figg, Lindsay
    Bhandari, Shruti
    Burd, Megan
    [J]. JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2021, 27 (07) : 1736 - 1742
  • [48] Checkpoint Inhibitors Common immune-related adverse events and their management
    Gordon, RuthAnn
    Kasler, Mary Kate
    Stasi, Kristen
    Shames, Yelena
    Errante, Mimma
    Ciccolini, Kathryn
    Lucas, Anna Skripnik
    Raasch, Pam
    Fischer-Cartlidge, Erica
    [J]. CLINICAL JOURNAL OF ONCOLOGY NURSING, 2017, 21 (02) : 45 - 52
  • [49] Immune-related cutaneous adverse events due to checkpoint inhibitors
    Wang, Evelyn
    Kraehenbuehl, Lukas
    Ketosugbo, Kwami
    Kern, Jeffrey A.
    Lacouture, Mario E.
    Leung, Donald Y. M.
    [J]. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2021, 126 (06) : 613 - 622
  • [50] Dermatologic immune-related adverse events to checkpoint inhibitors in cancer
    Shah, Neil J.
    Lacouture, Mario E.
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2023, 151 (02) : 407 - 409
12345